PhD in Biomedicine and Drug Development

For PhD in Biomedicine and Drug Development, tuition is 6,640,000 KRW per year.

Biomedicine and Drug Development focuses on the science behind how diseases develop at the biological level and how new therapies and pharmaceuticals are discovered, tested, and brought toward clinical use. A doctoral program in this field at Jeju National University in Jeju, South Korea, trains students to conduct original research spanning molecular and cellular biology, pharmacology, and the stages of drug discovery and development. Students combine advanced coursework with laboratory-based dissertation research, learning techniques for studying disease mechanisms, screening potential drug candidates, and evaluating their safety and effectiveness. The program is taught in English, making it accessible to international students who want doctoral training in biomedical and pharmaceutical research within a Korean university setting. Over two years and four semesters, students build the independent research capability expected of a doctoral graduate, with the option to begin study in either March or September. Because the field sits between basic biomedical science and applied pharmaceutical development, graduates are prepared for a range of career paths, including research positions in pharmaceutical and biotechnology companies, academic or government research institutions, and regulatory bodies that oversee drug approval. The doctoral-level training emphasizes not just understanding existing therapies but generating new knowledge that can move a candidate drug or biological insight further along the development pipeline, a skill set in demand as the pharmaceutical and biotechnology industries continue to expand their research operations.